![Carl Harald Janson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Harald Janson
Directeur/Membre du Conseil chez
Aprea Personal AB
Profil
Carl Harald Ramon Janson is currently a Director at KCIF Fund Management AB, Aprea Personal AB, and the owner of Carl Harald Janson Förvaltning AB. He previously held positions such as Chief Executive Officer & Director at Akinion Pharmaceuticals AB, Chief Executive Officer at KDev Oncology AB, and Director at Oncopeptides AB, Astra Arcus AB, Aprea Therapeutics AB, Axelar AB, ClanoTech AB, and Limone AB. He was also a Lead Manager-Investment at International Biotechnology Trust Plc from 2013 to 2021, a Portfolio Manager at Carnegie Fond AB from 2004 to 2007, and a Senior Portfolio Manager & Principal Fund Manager at Carnegie Investment Bank AB. Additionally, he was an Investment Manager at Karolinska Development AB (Private Equity) from 2008 to 2011, a Managing Partner at Zaramant Fonder AB from 2007 to 2008, and a Vice President-Portfolio Management at Karolinska Development AB. He holds a doctorate degree from Karolinska Institutet, which he received in 1990.
Postes actifs de Carl Harald Janson
| Sociétés | Poste | Début |
|---|---|---|
Aprea Personal AB | Directeur/Membre du Conseil | 21/04/2011 |
KCIF Fund Management AB | Directeur/Membre du Conseil | 21/04/2011 |
Carl Harald Janson Förvaltning AB | Corporate Officer/Principal | 21/04/2011 |
Anciens postes connus de Carl Harald Janson
| Sociétés | Poste | Fin |
|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Directeur en chef des Investissements | 15/03/2021 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Gestionnaire de Portefeuille-Actions | 01/02/2021 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Private Equity Investor | 31/12/2011 |
Zaramant Fonder AB
 Zaramant Fonder AB Investment ManagersFinance Provides Investment advice | Directeur en chef des Investissements | 01/01/2008 |
Carnegie Fond AB
 Carnegie Fond AB Investment ManagersFinance CF is an active investment manager following a growth-oriented investment approach. They invest in global equity across all market-caps, complemented with fixed-income, with the bulk of their investments in Swedish and US equity. Research is both performed in-house and shared with other Carnegie divisions. The firm's investment process is research-driven and starts with the analysis of long-term global trends. Sector allocation is top-down and based on macro-economic analysis focusing on the global economic cycle, inflation rates and development, future interest rate levels, and FX prices. Within select sectors, bottom-up stock-picking targets companies with growth potential. Stock selection is based on in-depth financial analysis, focusing on financial soundness, cash-flow analysis, profitability, growth history, management experience and ability, market position, ownership structure and stock liquidity. Company visits are part of the research process, as are reports by local analysts. | Gestionnaire de Portefeuille-Actions | 01/01/2007 |
Formation de Carl Harald Janson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
International Biotechnology Trust Plc
 International Biotechnology Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Carnegie Fond AB
Carnegie Fond AB Investment ManagersFinance CF is an active investment manager following a growth-oriented investment approach. They invest in global equity across all market-caps, complemented with fixed-income, with the bulk of their investments in Swedish and US equity. Research is both performed in-house and shared with other Carnegie divisions. The firm's investment process is research-driven and starts with the analysis of long-term global trends. Sector allocation is top-down and based on macro-economic analysis focusing on the global economic cycle, inflation rates and development, future interest rate levels, and FX prices. Within select sectors, bottom-up stock-picking targets companies with growth potential. Stock selection is based on in-depth financial analysis, focusing on financial soundness, cash-flow analysis, profitability, growth history, management experience and ability, market position, ownership structure and stock liquidity. Company visits are part of the research process, as are reports by local analysts. | Finance |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carnegie Investment Bank AB
 Carnegie Investment Bank AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Zaramant Fonder AB
Zaramant Fonder AB Investment ManagersFinance Provides Investment advice | Finance |
Astra Arcus AB | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
KCIF Fund Management AB | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
Limone AB
 Limone AB Pharmaceuticals: MajorHealth Technology Provides medical research | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Aprea Personal AB | |
Carl Harald Janson Förvaltning AB | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
